Chicago, May 27, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026", published by MarketsandMarkets™, is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%.

Browse in-depth TOC on "eClinical Solutions Market"
228 - Tables
38 - Figures
234 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=553

Increasing operational costs and regulatory requirements associated with clinical research studies;

The medical research and novel drug therapy industry is witnessing a shift from traditional drug-based treatment towards personalized or gene-based disease management. Government reimbursement bodies and private insurers & and payers often demand better therapeutic value and higher efficacy for novel drugs as compared to existing alternative therapies or medications. Moreover, these payer regulate standard pricing of novel medications, thereby lowering profit margins for manufacturing companies. The eClinical solutions industry is focusing on the enhancement & commercialization of software solutions that can facilitate early execution and completion of clinical trials in a cost-effective manner. Major pharmaceutical and biotechnology companies are adopting new business models to reduce their overall research cost, which is expected to drive the market demand for advanced and innovative eClinical solutions.

Cloud-based (SaaS) segment is projected to record the highest CAGR

On the basis of delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share (55.4%) of the global eClinical solutions market. However, the cloud-based (SaaS) segment is projected to record the highest CAGR (17.8%) in the forecast period. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) are fueling the growth of the cloud-based eClinical solutions market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=553

Scope of the eClinical Solutions Market

Report Metrics	Details
Market size available for years	2022–2026
Base year considered	2020
Largest Market	North America
Forecast Period 2022-2026 CAGR	13.3%
Estimated Year Market Size	USD 8.3 billion
Forecast Year Market Size	USD 15.4 billion
Segments covered	By Product, By Delivery mode, By Clinical trials phases, By End User & By Region
Geographies covered	North America, Europe, Asia Pacific, ROW
Companies covered	Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US) and others.

Phase III clinical trials is expected to register the highest growth during the forecast period

On the basis of clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share (52.0%) of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.

CROs segment is estimated to record the highest CAGR in the forecast period.

On the basis of end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share (38.4%) of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=553

North America to Witness Significant Growth from 2021 To 2026

North America commanded the largest share (60.1%) of the eClinical solutions market in 2020. Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region. Europe accounted for the second-largest share of the global eClinical solutions market in 2020. This can be attributed to the large number of ongoing clinical trials and rising investments by pharmaceutical and biopharmaceutical companies to support their drug development pipeline.

Key Players

• Oracle Corporation (US)
• Medidata Solutions, Inc. (US)
• Parexel International Corporation (US)
• BioClinica, Inc. (US)
• Signant Health (US)
• Datatrak International, Inc. (US)
• ERT (US)
• eClinical Solutions, Inc. (US)
• MaxisIT Inc. (US)
• Bio-Optronics, Inc. (US)
• Merge Healthcare Incorporated (US)
• OmniComm Systems, Inc. (US)

Oracle Corporations is one of the top players in the global eclinical solutions market in 2020. The company’s robust product portfolio and diversified geographic presence and customer base contributes to its position in the market. Oracle Corporation primarily focuses on product developments and launches to expand its footprint in the global market. It company also focuses on collaborations and alliances with leading biopharma companies to enhance its customer base across the globe.
Browse Adjacent Markets @ Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user (Providers, Payer) - Global Forecast to 2026

Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) - Global Forecast 2026

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=553

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com